Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Claire Advokat"'
Publikováno v:
Journal of the History of the Neurosciences. 21:263-279
Research on the neurobiology and pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) has grown exponentially since 1980. A reasonable question is whether this research has improved our understanding and treatment of ADHD. This article
Autor:
Claire Advokat
Publikováno v:
Clinical Schizophrenia & Related Psychoses. 3:226-236
Akathisia is a significant and serious neurological side effect of many antipsychotic and antidepressant medications. It is most often expressed as a subjective, uncomfortable, inner restlessness, which produces a constant compulsion to be in motion,
Autor:
Claire Advokat, Katie Barrilleaux
Publikováno v:
Journal of Attention Disorders. 12:291-298
Objective: To determine if adults with ADHD differed from children with ADHD, in assessing their performance on the Conners Continuous Performance Test (CPT). Method: ADHD-diagnosed adults ( n = 13) and adults without ADHD ( n = 17) were tested twice
Publikováno v:
Psychiatric Quarterly. 79:55-64
The purpose of this study was to determine if Second-Generation Antipsychotics (SGAs), relative to First-Generation Antipsychotics (FGAs), reduced either the length of stay (LOS) or number of re-hospitalizations of schizophrenic patients receiving tr
Autor:
Claire Advokat
Publikováno v:
Journal of Attention Disorders. 11:8-16
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was conducted, to obtain information on the long-term neurological consequences of this therapy. Method: Several databases were accessed for research art
Publikováno v:
Journal of Attention Disorders. 10:253-256
Objective/Method: The Conner’s Continuous Performance Test (CPT) was administered to four groups of adult college students who self-referred for comprehensive psychoeducational evaluation and received either no diagnosis ( n = 30) or a diagnosis of
Autor:
Claire Advokat, Joseph E. Comaty
Publikováno v:
Journal of Mental Health. 15:57-62
Background: Concerns about the therapeutic and neurological benefits of Second Generation Antipsychotics (SGAs), and financial conflicts of interest and possible biases in the recruitment of research participants, prompted this “real world” study
Publikováno v:
Psychiatric Quarterly. 76:97-106
The lifetime outcome for individuals diagnosed with affective disorders is generally more favorable than for those diagnosed with a schizophrenic disorder. We determined if a similar differential outcome could be detected among 139 patients hospitali
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28:487-495
As a follow-up to our previous study of clozapine, medical records of a state psychiatric hospital were reviewed for patients who were prescribed an atypical antipsychotic. From that sample, demographic and clinical data were obtained for individuals
Publikováno v:
Archives of Clinical Neuropsychology. 17:305-318
Differences in verbal and nonverbal olfactory identification and recognition were examined among three groups with brain impairment. A left cerebrovascular accident (LCVA) group, a right CVA (RCVA) group, and a traumatic brain injury (TBI) group were